VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZC”) (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received a final patent from South Africa PCT patent PCT-IL 2023050243 in South Africa. In addition, the company is actively pursuing a global patent portfolio with applications filed worldwide including in the United States, Brazil, and Europe.
Public Announcements
- Zero Candida
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Supports GLP preclinical testing and planned Q4 2026 clinical study of at least 100 women VANCOUVER, BC, Feb. 17, 2026 /PRNewswire/ — Zero Candida Technologies,…
- Zero Candida
Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device
Zero Candida Technologies, Inc. (TSXV: ZCT)(OTCQB: ZCTFF)(FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device company focused on revolutionizing women’s health, is pleased to…
- Zero Candida
Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update
Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a Femtech company developing a SMART, AI-driven medical device to…
- Zero Candida
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Supports GLP preclinical testing and planned Q4 2026 clinical study of at least 100 women VANCOUVER, BC, Feb. 17, 2026 /PRNewswire/ — Zero Candida Technologies,…
- Zero Candida
Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device
Zero Candida Technologies, Inc. (TSXV: ZCT)(OTCQB: ZCTFF)(FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device company focused on revolutionizing women’s health, is pleased to…
- Zero Candida
Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update
Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a Femtech company developing a SMART, AI-driven medical device to…
- Zero Candida
Zero Candida Technologies Announces DTC Eligibility and to Present at OTCQB Venture Virtual Investor Conference on August 7th
VANCOUVER, BC, Aug. 5, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device…
- Zero Candida
Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights
VANCOUVER, BC, April 2, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device…
- Zero Candida
Zero Candida Commences Trading on OTCQB Market
VANCOUVER, BC, March 12, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device…
- Zero Candida
Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030
VANCOUVER, BC, Feb. 3, 2025 /PRNewswire/ — A market analysis made by Moore Financial Consulting published today estimate the global market for Zero Candida Technologies,…
- Zero Candida
Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar
VANCOUVER, BC, Jan. 16, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the “Company” or “ZCT”), an Israeli FemTech medical device company…
- Zero Candida
Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025
VANCOUVER, BC, January 06, 2025 /PRNewswire/ — Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the “Company” or “ZCT”), an Israeli FemTech medical device company…
- Zero Candida
Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)
VANCOUVER, BC, Nov. 25, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZCT”), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce…
